Ricardo Perdigão Henriques, PhD

Managing Partner

Ricardo Perdigão Henriques is the Managing Partner of Biovance Capital. Ricardo has over 15 years of experience in the biomedical sector in USA and Portugal, including scientific research, venture capital and pharmaceutical industry. Prior to joining Biovance, Ricardo was the CEO of Bionova Capital. Previously, Ricardo was an investment manager at Portugal Ventures and an international business analyst at BIAL Pharma.
Ricardo is a Harvard and MIT-educated scientist with a BSc in Biochemistry and a PhD in Molecular Oncology, with publications in high-ranking journals such as the Journal of Clinical Investigation, Nature Publishing Group’s Oncogene, and Biotechnology Progress.

Peter Villax


Peter Villax is a Partner at Biovance Capital. Peter has over 40 years of experience in the pharmaceutical industry in IT, sales, R&D and business administration. He joined Hovione in 1982 as a computer programmer and led Hovione’s computerization. He then switched to pharmaceutical development in 1990 and soon became interested in pulmonary delivery. His disposable dry-powder inhaler TwinCaps, licensed to Daiichi Sankyo for the delivery of Influenza drug Inavir®, continues to be the only commercial device of its kind in the world, and has helped Daiichi Sankyo become the market leader in influenza products in Japan. He acquired significant experience as an inventor of devices, as a patentholder and as a licensor of technology patents. Peter founded Bionova Capital in 2015, having been its CEO from 2015 to 2019. In 2019, he became the Chairman of Bionova Capital. Peter is the President of the Portuguese Family Business Association and Board member of civic and academic bodies.

João Botelho


João Botelho is the CFO of Biovance Capital. João has over 15 years of experience in Auditing, Finance and Private Equity. Prior to joining Biovance, João was the Finance Director of Bionova Capital. Previously, he was Financial and Business Controller at ECS Capital, overseeing a € 1bn private equity fund. He previously was Senior Auditor at Ernst & Young. João holds a Master’s Degree in Advanced Financial Accounting.